Rein Therapeutics, Inc. financial data

Symbol
RNTX on Nasdaq
Location
12407 N. Mopac Expy., Suite 250 #390, Austin, TX
Fiscal year end
December 31
Latest financial report
10-Q - Q2 2025 - Aug 14, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 189 % -56.4%
Debt-to-equity 8.47 % -51.7%
Return On Equity -33.4 % +67.3%
Return On Assets -84.1 % -173%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 23.3M shares +7.57%
Common Stock, Shares, Outstanding 23M shares +6.57%
Entity Public Float 54.1B USD +721%
Common Stock, Value, Issued 109K USD +1.87%
Weighted Average Number of Shares Outstanding, Basic 24.2M shares +21.5%
Weighted Average Number of Shares Outstanding, Diluted 24.2M shares +21.5%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 0 USD
Research and Development Expense 14.4M USD +56.4%
General and Administrative Expense 9.96M USD -39%
Operating Income (Loss) -61.3M USD -140%
Net Income (Loss) Attributable to Parent -59.2M USD -135%
Earnings Per Share, Basic -2 USD/shares +17%
Earnings Per Share, Diluted -2 USD/shares +17%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 5.72M USD -73.9%
Cash, Cash Equivalents, and Short-term Investments 13.7M USD -57.8%
Other Assets, Current 692K USD +128%
Assets, Current 6.6M USD -71.5%
Property, Plant and Equipment, Net 1K USD -50%
Intangible Assets, Net (Excluding Goodwill) 42.2M USD -46.7%
Goodwill 6.33M USD 0%
Other Assets, Noncurrent 2.35M USD +231%
Assets 57.5M USD -47.5%
Accounts Payable, Current 6.03M USD +671%
Employee-related Liabilities, Current 640K USD -55.4%
Liabilities, Current 7.69M USD +55.8%
Deferred Income Tax Liabilities, Net 1.77M USD -46.7%
Other Liabilities, Noncurrent 0 USD -100%
Liabilities 9.47M USD +13%
Accumulated Other Comprehensive Income (Loss), Net of Tax -44K USD -100%
Retained Earnings (Accumulated Deficit) -364M USD -19.4%
Stockholders' Equity Attributable to Parent 48M USD -52.5%
Liabilities and Equity 57.5M USD -47.5%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -6.18M USD -17.2%
Net Cash Provided by (Used in) Financing Activities 738K USD
Net Cash Provided by (Used in) Investing Activities 0 USD -100%
Common Stock, Shares Authorized 100M shares 0%
Common Stock, Shares, Issued 23M shares +6.57%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -5.44M USD -3.15%
Deferred Tax Assets, Valuation Allowance 30.5M USD +64.6%
Deferred Tax Assets, Gross 37.5M USD +18%
Depreciation 13K USD -13.3%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -59.2M USD -134%
Property, Plant and Equipment, Gross 377K USD +10.9%
Operating Lease, Liability, Current 48K USD +45.5%
Lessee, Operating Lease, Liability, to be Paid, Year One 48K USD +37.1%
Operating Lease, Weighted Average Discount Rate, Percent 0.07 pure -41.7%
Deferred Tax Assets, Operating Loss Carryforwards 17.4M USD +40.7%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 5M shares 0%
Unrecognized Tax Benefits 0 USD
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization 0 USD -100%
Deferred Tax Assets, Net of Valuation Allowance 7.05M USD -46.9%
Share-based Payment Arrangement, Expense 1.16M USD +19.1%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%